Stocksigma LogoStocksigma Logo

Par Drugs & Chemicals Reports Q2 FY27 Financial Results

Par Drugs and Chemicals approved its standalone financial results for the quarter ended 30th Sep'26. Revenue from operations reached Rs 2,743.19 lakhs

Par Drugs & Chemicals Reports Q2 FY27 Financial Results

Par Drugs and Chemicals Ltd 路 Outcome 路 29 Oct 2026, 10:35 pm

Par Drugs & Chemicals Reports Q2 FY27 Financial Results Par Drugs and Chemicals approved its standalone financial results for the quarter ended 30th Sep'26. Revenue from operations reached Rs 2,743.19 lakhs, down 12.30% QoQ from Rs 3,128.05 lakhs in Jun'26 and 4.28% YoY from Rs 2,865.89 lakhs in Sep'25. Net profit dropped 44.23% QoQ and 36.36% YoY to Rs 262.80 lakhs, yielding an EPS of Rs 2.14 compared to Rs 3.83 in Jun'26 and Rs 3.36 in Sep'25. For H1 ended 30th Sep'26, revenue stood at Rs 5,871.24 lakhs with net profit of Rs 734.07 lakhs.

Original exchange filing (PDF)

More announcements from Par Drugs and Chemicals Ltd

All Par Drugs and Chemicals Ltd announcements